Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Catecholamine-resistant hypotension -- an update].

H Groeben1, B W Böttiger, M Schäfer

  • 1Klinik für Anästhesiologie, Schmerz- und Intensivtherapie, Kliniken Essen-Mitte. harald.groeben@uni-essen.de

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|July 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting CPR skills dissemination in schools and communities: the adapted Szpilman's mannikin and AED.

Resuscitation plus·2026
Same author

Barriers and facilitators while implementing community first responder systems in a western setting: mixed-methods expert consensus.

International journal of emergency medicine·2026
Same author

Barriers and enablers to public access defibrillation - an international RAND-UCLA consensus study.

Scandinavian journal of trauma, resuscitation and emergency medicine·2026
Same author

[The new European Resuscitation Council (ERC) guidelines 2025-Overview of the most important changes; the first 3-5 min are decisive].

Die Anaesthesiologie·2025
Same author

Letter to the Editor: 250th cardiac arrest center certification in Germany.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Kids and others save lives - All generations globally involved in World Restart a Heart 2024 to save the world!

Resuscitation plus·2025
Same journal

[Infection Prevention in the Intensive Care Unit: Evidence-Based Strategies for Reducing Healthcare-Associated Infections].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Persistent Postoperative Opioid Use].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Dexamethasone for Perioperative Analgesia].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Treatment Expectations in the Perioperative Setting - Influence on Postoperative Pain Treatment].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Correction: Anaesthesiological Concepts in Paediatric Neurosurgery].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
See all related articles

Vasoplegia, a catecholamine-resistant hypotension, is challenging in shock and post-bypass. Vasopressin and methylene blue show promise but require more evidence for standard use.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Vasoplegia, or catecholamine-resistant hypotension, complicates severe hemorrhagic shock, septic shock, and post-cardiopulmonary bypass.
  • The underlying mechanisms, including ATP depletion, vasopressin dysregulation, and potassium channel activation, remain incompletely understood.
  • While ATP-dependent potassium channel activation is a focus, with glibenclamide as a potential inhibitor, it doesn't universally resolve hypotension, particularly in septic shock.

Purpose of the Study:

  • To review the current understanding and therapeutic options for vasoplegia.
  • To evaluate the evidence for vasopressin and methylene blue in treating catecholamine-resistant hypotension.
  • To highlight the need for further controlled studies on efficacy, dosing, and safety.

Main Methods:

Related Experiment Videos

  • Review of existing literature, including case reports, uncontrolled series, and initial randomized controlled trials.
  • Analysis of potential mechanisms and therapeutic targets for vasoplegia.
  • Examination of clinical data on vasopressin and methylene blue, including efficacy and side effects.

Main Results:

  • Vasoplegia is a complex condition with multiple proposed underlying mechanisms.
  • Vasopressin and methylene blue have shown success in case reports and uncontrolled studies for catecholamine-resistant hypotension.
  • Early randomized controlled trials in post-cardiopulmonary bypass hypotension demonstrate successful blood pressure restoration and reduced mortality with these agents.

Conclusions:

  • Vasoplegia management remains challenging, especially in hemorrhagic and septic shock, with limited high-quality evidence for treatments like vasopressin and methylene blue.
  • While not standard therapy, vasopressin and methylene blue offer a potential option for life-threatening vasoplegia in select cases.
  • Further placebo-controlled studies are crucial to establish optimal use, dosing, and safety profiles, particularly regarding risk factors and non-responder prediction.